| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3392302 | Transplant Immunology | 2009 | 5 Pages |
Abstract
The use of porcine organs for clinical transplantation is a promising potential solution to the shortage of human organs. Preformed anti-pig antibody is the primary cause of hyperacute rejection, while elicited antibody can contribute to subsequent “delayed” xenograft rejection. This article will review recent progress to overcome antibody mediated xenograft rejection, through modification of the host immunity and use of genetically engineered pig organs.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Richard N. Pierson III,